Prof Andrew Christie is launching the auDRP Overview, an analysis of decisions under the auDRP on Wednesday 27 August 2014 at 9:15am.
The Rosuvastatin case is that rare beast – a decision of a 5 member Full Bench of the Federal Court. It canvases many issues and, no doubt, we shall be picking over it for years to come. Susan Gatford, at the Victorian Bar, has kindly provided a guest post on the section 40 issues.
Perram J has ruled that additional damages can be awarded for conduct occurring before the statutory power was inserted in the Trade Marks Act.
The 5 member Full Bench of the Federal Court has dismissed AstraZeneca’s appeal in the “rosuvastatin” case.
IP Australia has published a report on patent pendency in Australia
The online copyright infringement discussion paper has been released officially.